Drägerwerk stock slips 1.05% to EUR 103.70 pre-market
Published on 11/06/2026 at 08:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Moves Drägerwerk Before Xetra
- Dräger makes medical and safety technology for hospitals, emergency services and industry.
- The company lists confirmed 2026 guidance of 2.0% to 6.0% currency-adjusted revenue growth and a 6.0% to 8.0% EBIT margin.
- The pre-market indication points to a weaker start for the stock before Xetra trading.
Drägerwerk stock traded at 103.70 euros on Lang & Schwarz at 08:19 CET on Friday, November 6, 2026, 1.05 percent below the Xetra close of Thursday, November 5, at 104.80 euros.
The pre-market indication points to a weaker start for the preferred shares before the next Xetra session. It measures the current quotation against the latest completed Xetra close and does not establish a cause for the move.
Drägerwerk makes products for medical and safety technology. Its business serves hospitals, fire brigades, emergency services, authorities, mining and industrial companies. The company's investor-relations page says Dräger employs around 16,700 people and operates in more than 190 countries.
2026 Outlook Remains Confirmed
Dräger's current 2026 outlook calls for currency-adjusted revenue growth of 2.0% to 6.0% and an EBIT margin of 6.0% to 8.0%. The company also lists a confirmed gross-margin range of 44.0% to 46.0% and a DVA range of EUR 60 million to EUR 140 million.
For investors, the next trading session will show whether the pre-market weakness carries into regular Xetra trading. The confirmed outlook keeps revenue and profitability targets in focus while the market weighs the latest quotation.
German equities will trade within the broader DAX market environment.
More news and analyses on Drägerwerk stock provide further coverage of the company and its shares.
